CURATIVE VENTURES V LLC
Q3 2024 Form 13-F
DALLAS, TEXAS
CIK 0001754072
· Institutional investment manager
$127.8M Reported Value Total
Reported value
$127.8M
Quarter over quarter
+554.2%
Holdings
1
Top-10 concentration
100.0%
Key People
Named on the latest Form 13-F filing — not necessarily an owner
Bronson Crouch
Manager of CV-Immetacyte Manager LP
Filing Navigation
13F Metrics
Loading 13F Metrics
Q3 2024 13F record
Q3 2024 13F filing summary
| Period of report | September 30, 2024 |
|---|---|
| Filed | October 31, 2024 |
| Form | 13F-HR |
| Reported value | $127.8M |
| Positions | 1 |
| Change in reported value | +554.2% |
| New positions | 0 |
| Exited positions | 0 |
| Position turnover | 0.0% |
| Top-10 concentration | 100.0% |
13F filings by quarter
| Quarter | Positions | Value |
|---|---|---|
|
Q3 2026 13F
Filed Nov 3, 2026
|
1 | $13.7M |
|
Q2 2026 13F
Filed Jul 31, 2026
|
1 | $14.6M |
|
Q1 2026 13F
Filed Apr 29, 2026
|
1 | $15.6M |
|
Q4 2025 13F
Filed Feb 3, 2026
|
1 | $20.9M |
|
Q3 2025 13F
Filed Nov 3, 2025
|
1 | $33.9M |
|
Q2 2025 13F
Filed Jul 29, 2025
|
1 | $39.6M |
|
Q1 2025 13F
Filed Apr 30, 2025
|
1 | $33.0M |
|
Q4 2024 13F
Filed Jan 29, 2025
|
1 | $36.3M |
|
Q3 2024 13F
Filed Oct 31, 2024
|
1 | $127.8M |
|
Q2 2024 13F
Filed Jul 17, 2024
|
1 | $19.5M |
|
Q1 2024 13F
Filed May 8, 2024
|
1 | $20.5M |
|
Q4 2023 13F
Filed Feb 12, 2024
|
1 | $14.5M |
|
Q3 2023 13F
Filed Nov 13, 2023
|
1 | $16.3M |
|
Q2 2023 13F
Filed Aug 2, 2023
|
1 | $20.9M |
|
Q1 2023 13F
Filed May 8, 2023
|
1 | $25.1M |
|
Q4 2022 13F
Filed Jan 30, 2023
|
1 | $23.9M |
|
Q3 2022 13F
Filed Nov 10, 2022
|
1 | $183.8M |
|
Q2 2022 13F
Filed Aug 4, 2022
|
1 | $175.5M |
|
Q1 2022 13F
Filed May 13, 2022
|
1 | $408.3M |
|
Q4 2021 13F
Filed Feb 14, 2022
|
1 | $649.8M |
Top 1 holdings · Q3 2024
| # | Holding | Reported value | % of portfolio |
|---|---|---|---|
| 1 | TIL Instil Bio, Inc. | $127.8M | 100.0% |
Values as reported on the Q3 2024 Form 13F. Every position is in the holdings table below.